Meta-analysis statistically assesses the results (e.g., effect sizes) across independent studies that are conducted in accordance with similar protocols and objectives. Current genomic meta-analysis studies do not perform extensive re-analysis on raw data because full data access would not be commonplace, although the best practice of open research for sharing well-formed data have been actively advocated. This chapter describes a simple and easy-to-follow method for conducting meta-analysis of multiple studies without using raw data. Examples for meta-analysis of microRNAs (miRNAs) are provided to illustrate the method. MiRNAs are potential biomarkers for early diagnosis and epigenetic monitoring of diseases. A number of miRNAs have been identified to be differentially expressed, i.e., overexpressed or underexpressed, under diseased states but only a small fraction would be highly effective biomarkers or therapeutic targets of diseases. The meta-analysis method as described in this chapter aims to identify the miRNAs that are consistently found dysregulated across independent studies as biomarkers.
CITATION STYLE
Zhu, H., & Leung, S. wai. (2018). Identification of potential microRNA biomarkers by meta-analysis. In Methods in Molecular Biology (Vol. 1762, pp. 473–484). Humana Press Inc. https://doi.org/10.1007/978-1-4939-7756-7_24
Mendeley helps you to discover research relevant for your work.